Puma Biotechnology reported $5K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31343M 96M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Cerulean Pharma CERU:US $ 0.01M 0M
Clovis Oncology CLVS:US $ 0.14M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
Esperion Therapeutics ESPR:US $ 65K 4K
Exelixis EXEL:US $ 0.32M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Macrogenics MGNX:US $ 0.62M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Moderna Inc MRNA:US 39.2K 800
Novartis NOVN:VX SF 890M 11M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sangamo Biosciences SGMO:US $ 1.53M 0.07M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Spectrum Pharmaceuticals SPPI:US $ 0.18M 0.01M
Takeda 4502:JP Y 1676277M 14M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M
YTE INCY:US $ 0.22M 0M